Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Melanoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 9ruxolitinib 7Azacitidine 7fludarabine phosphate 6Whole-Body Irradiation 6Peripheral Blood Stem Cell Transplantation 6Mycophenolic Acid 6navitoclax 5fludarabine 5Therapeutics 5Busulfan 5ponatinib 4Melphalan 4Tacrolimus 3Stem Cell Transplantation 3Patient Reported Outcome Measures 3Mesna 3Immunoenzyme Techniques 3Flow Cytometry 3Cyclosporine 3Clofarabine 3Antilymphocyte Serum 3vosaroxin 2trametinib 2liposomal amphotericin B 2dabrafenib 2Watchful Waiting 2Transplantation 2Sirolimus 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Nurse Clinicians × Myeloid × Clear all
NCT00179764 2019-08-30

Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

Ann & Robert H Lurie Children's Hospital of Chicago

Phase NA Completed
68 enrolled
DermatologicLymphoidMyeloidOther hematologic neoplasm

Melanoma, Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡